Marshall Wace, LLP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $277 Million - $291 Million	-1,909,218 Reduced 98.99%	19,406 $2.93 Million
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $39.3 Million - $69 Million	-472,660 Reduced 19.68%	1,928,624 $281 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $43.7 Million - $56.8 Million	-397,173 Reduced 14.19%	2,401,284 $285 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $8.01 Million - $11.9 Million	80,272 Added 2.95%	2,798,457 $386 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $1.4 Million - $1.97 Million	-14,183 Reduced 0.52%	2,718,185 $378 Million
Q2 2021 Aug 13, 2021	SELL	$65.78 - $105.02 $2.9 Million - $4.63 Million	-44,099 Reduced 1.59%	2,732,368 $265 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $14.1 Million - $20.2 Million	219,915 Added 8.6%	2,776,467 $190 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $1.87 Million - $2.82 Million	28,702 Added 1.14%	2,556,552 $219 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $1.56 Million - $2.06 Million	26,406 Added 1.06%	2,527,850 $164 Million
Q2 2020 Aug 13, 2020	SELL	$29.01 - $74.23 $1.8 Million - $4.6 Million	-61,999 Reduced 2.42%	2,501,444 $183 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $63.6 Million - $133 Million	2,312,881 Added 923.08%	2,563,443 $87.2 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $11.7 Million - $16.6 Million	-287,235 Reduced 53.41%	250,562 $13.6 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $9.41 Million - $12.5 Million	251,836 Added 88.07%	537,797 $22.4 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $11.1 Million - $18.7 Million	278,863 Added 3928.75%	285,961 $12.5 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $245,022 - $378,252	7,098 New	7,098 $365,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account